Morgan Stanley’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$41M Sell
170,103
-26,521
-13% -$6.4M ﹤0.01% 2110
2025
Q1
$47.9M Sell
196,624
-51,662
-21% -$12.6M ﹤0.01% 1859
2024
Q4
$81.6M Buy
248,286
+61,334
+33% +$20.1M 0.01% 1413
2024
Q3
$62.6M Sell
186,952
-30,064
-14% -$10.1M ﹤0.01% 1627
2024
Q2
$59.3M Sell
217,016
-35,324
-14% -$9.65M ﹤0.01% 1591
2024
Q1
$87.3M Sell
252,340
-247,802
-50% -$85.7M 0.01% 1293
2023
Q4
$161M Buy
500,142
+286,254
+134% +$92.4M 0.01% 1309
2023
Q3
$76.7M Buy
213,888
+14,408
+7% +$5.16M 0.01% 1239
2023
Q2
$75.6M Buy
199,480
+5,263
+3% +$2M 0.01% 1259
2023
Q1
$93M Buy
194,217
+3,096
+2% +$1.48M 0.01% 1097
2022
Q4
$80.4M Buy
191,121
+53,491
+39% +$22.5M 0.01% 1175
2022
Q3
$57.4M Sell
137,630
-5,379
-4% -$2.24M 0.01% 1225
2022
Q2
$70.8M Buy
143,009
+76,782
+116% +$38M 0.01% 1138
2022
Q1
$37.3M Sell
66,227
-48,897
-42% -$27.5M 0.01% 1511
2021
Q4
$87M Buy
115,124
+44,201
+62% +$33.4M 0.01% 982
2021
Q3
$52.9M Buy
70,923
+6,251
+10% +$4.66M 0.01% 1256
2021
Q2
$41.7M Buy
64,672
+36,109
+126% +$23.3M 0.01% 1461
2021
Q1
$16.3M Sell
28,563
-16,281
-36% -$9.3M ﹤0.01% 2138
2020
Q4
$26.1M Buy
44,844
+9,946
+29% +$5.8M ﹤0.01% 1566
2020
Q3
$18M Buy
34,898
+15,301
+78% +$7.89M ﹤0.01% 1562
2020
Q2
$8.85M Buy
19,597
+1,289
+7% +$582K ﹤0.01% 2076
2020
Q1
$6.42M Sell
18,308
-7,850
-30% -$2.75M ﹤0.01% 2211
2019
Q4
$9.68M Buy
26,158
+15,136
+137% +$5.6M ﹤0.01% 2470
2019
Q3
$3.67M Sell
11,022
-7,666
-41% -$2.55M ﹤0.01% 3211
2019
Q2
$5.84M Sell
18,688
-89,675
-83% -$28M ﹤0.01% 2759
2019
Q1
$33.1M Buy
108,363
+26,184
+32% +$8M 0.01% 1083
2018
Q4
$19.1M Buy
82,179
+59,621
+264% +$13.8M 0.01% 1498
2018
Q3
$7.06M Sell
22,558
-16,263
-42% -$5.09M ﹤0.01% 2797
2018
Q2
$11.2M Sell
38,821
-54,050
-58% -$15.6M ﹤0.01% 2245
2018
Q1
$23.2M Buy
92,871
+34,400
+59% +$8.6M 0.01% 1535
2017
Q4
$14M Buy
58,471
+13,782
+31% +$3.29M ﹤0.01% 2050
2017
Q3
$9.93M Buy
44,689
+13,650
+44% +$3.03M ﹤0.01% 2281
2017
Q2
$7.03M Sell
31,039
-10,301
-25% -$2.33M ﹤0.01% 2508
2017
Q1
$8.24M Sell
41,340
-798,648
-95% -$159M ﹤0.01% 2394
2016
Q4
$153M Buy
839,988
+381,712
+83% +$69.6M 0.05% 394
2016
Q3
$75.1M Buy
458,276
+299,804
+189% +$49.1M 0.03% 644
2016
Q2
$22.7M Buy
158,472
+146,904
+1,270% +$21M 0.01% 1324
2016
Q1
$1.58M Sell
11,568
-59,986
-84% -$8.2M ﹤0.01% 3541
2015
Q4
$9.92M Buy
71,554
+55,884
+357% +$7.75M ﹤0.01% 1992
2015
Q3
$2.11M Sell
15,670
-30,545
-66% -$4.1M ﹤0.01% 3463
2015
Q2
$6.96M Buy
46,215
+10,565
+30% +$1.59M ﹤0.01% 2481
2015
Q1
$4.82M Sell
35,650
-17,530
-33% -$2.37M ﹤0.01% 2791
2014
Q4
$6.41M Sell
53,180
-14,001
-21% -$1.69M ﹤0.01% 2490
2014
Q3
$7.62M Buy
67,181
+47
+0.1% +$5.33K ﹤0.01% 2271
2014
Q2
$8.04M Buy
67,134
+19,374
+41% +$2.32M ﹤0.01% 2226
2014
Q1
$6.12M Sell
47,760
-361,990
-88% -$46.4M ﹤0.01% 2376
2013
Q4
$50.6M Buy
409,750
+35,465
+9% +$4.38M 0.02% 728
2013
Q3
$44M Sell
374,285
-7,012
-2% -$824K 0.02% 743
2013
Q2
$42.8M Buy
+381,297
New +$42.8M 0.02% 717